Article
The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma
21 Jul 2021
Abstract excerpt
Early detection improves survival and increases curative probability in hepatocellular carcinoma (HCC). Peripheral blood mononuclear cells (PBMCs) can provide an inexpensive, less-invasive and highly accurate method. The objective of this study is to find the potential marker for HCC screening, utilizing gene expression of the PBMCs. Data from the NCBI GEO database of gene expression in HCC patients and healthy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
